Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.
Age-related memory loss was reversed by boosting blood levels of osteocalcin, a hormone produced by bone cells, in mice.
Memories "lost" to Alzheimer's disease may just be hard to retrieve, suggests a new study by neuroscientists at Columbia University Medical Center.